Mala-Nil

Malanil Tablets for Malaria Prophylaxis and Treatment

Malanil is a fixed-dose combination medication that effectively treats and prevents malaria, particularly the drug-resistant form of Plasmodium falciparum. This product contains atovaquone and proguanil hydrochloride, which work together to target both the blood and liver stages of the malaria parasite.

Indications

• Prophylaxis: Malanil is recommended for preventing malaria in areas where the parasite may be resistant to other antimalarials. It should be taken one to two days before entering a malaria-endemic area and continued daily until seven days after leaving the area.
• Treatment: Malanil is also used to treat malaria infections. The adult treatment dose involves taking four standard tablets once a day for three consecutive days. For children, the dosage varies based on body weight.

Dosage and Administration

• Adults: One tablet daily for prophylaxis, taken with food or a milky drink at the same time each day.
• Children: Dosage depends on body weight:
• 11-20 kg: One low-strength tablet daily.
• 21-30 kg: Two low-strength tablets daily.
• 31-40 kg: Three low-strength tablets daily.
• Greater than 40 kg: One high-strength tablet daily.
• Treatment: Four high-strength tablets as a single dose for three consecutive days.

Important Information

• Contraindications: Malanil is contraindicated in breastfeeding and in individuals allergic to its components. Always consult a doctor before taking Malanil.
• Precautions: Overdose symptoms should be managed with symptomatic and supportive therapy.

Product Details

Each low-strength tablet contains 62.5 mg of atovaquone and 25 mg of proguanil hydrochloride. The tablets are film-coated, round, and biconvex, with a pink color. Malanil is effective against both drug-sensitive and drug-resistant strains of P. falciparum, making it a reliable choice for malaria prevention and treatment in areas with high resistance levels.